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Abstract 
Proliferation of an essential fatty acid deficient  cell line from carp (EPC-EFAD; epithelioma 
papillosum carp-essential fatty acid deficient) is stimulated by supplementing the cells with C20, 
but not C18 polyunsaturated fatty acids (PUFA). It is hypothesized that the differential ability of 
the PUFA to stimulate proliferation of the EPC-EFAD cells may be related to the extent of the 
cells’ ability to desaturate and elongate C18 PUFA.  In the present study, the metabolism of 14C-
labeled C18 and C20 PUFA was investigated in EPC-EFAD cells in comparison with normal EPC 
cells.  The incorporation of all the PUFA was significantly greater in EPC-EFAD cells but the 
rank order, 20:5n-3 > 18:3n-3 = 18:2n-6 >20:4n-6 was the same in both cell lines. The 
proportion of radioactivity from all labeled PUFA recovered in phosphatidylethanolamine and 
total polar lipids was significantly lower in EPC-EFAD cells compared to EPC cells, whereas the 
proportion of radioactivity recovered in all the other phospholipid classes and total neutral lipid 
was greater in EPC-EFAD cells.  Both cell lines desaturated[1-14C]18:3n-3 and [1-14C]20:5n-3 to 
a greater extent than the corresponding (n-6) substrates but the desaturation of all the  14C-labeled 
PUFA was significantly greater in EPC-EFAD cells compared to EPC cells.  The results showed 
that, although essential fatty acid deficiency had several significant effects on PUFA metabolism 
in EPC cells, the fatty acid desaturation/elongation pathway was not impaired in EPC-EFAD 
cells and so they can desaturate 18:3n-3 to 20:5n-3 and 22:6n-3, and 18:2n-6 to 20:4n-6.   
However, 20:4n-3 and 20:3n-6, and not 20:4n-6 and 20:5n-3, were the predominant C20 PUFA 
produced by the elongation and desaturation  of [1-14C]18:3n-3 and [1-14C]18:2n-6, respectively.  
Therefore, the previously reported inability of 18:3n-3 and 18:2n-6, compared to 20:5n-3 and 
20:4n-6,  to stimulate proliferation of the cells is apparently not due to a general deficiency in the 
fatty acid desaturation pathway in EPC-EFAD cells but may be related to potential differences in 
eicosanoid profiles in cells supplemented with C18 PUFA compared to C20 PUFA. 
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Introduction 
 
Cultured cells have been an important in vitro tool in the study of lipid and fatty acid metabolism 
in mammals (Bailey and Dunbar 1973; Ferguson et al. 1975; Maeda et al. 1978; Spector et al. 
1981; Masuzawa et al. 1986; Isseroff et al. 1987).   Most cells in culture, including fish cells,  
generally require the medium to be supplemented with serum which, along with various 
hormones and growth factors, also provides lipid and fatty acids to the cells (Sato  1975; Bailey 
and Dunbar 1973).  Despite this, mammalian cell lines have been developed that can grow in 
either serum-free medium or delipidated sera which has enabled the effects of essential fatty acid 
deficiency to be investigated in cell lines in vitro (Laposata et al. 1982; Marcelo et al. 1992; 
Lerner et al. 1995).  The development of a fish cell line that could grow in the absence of serum, 
and hence exogenously added fatty acids, had added importance as the commercial mammalian 
sera used in cell culture, including fish cell culture, distort the fatty acid composition of the fish 
cells in that they display lower percentages of n-3 PUFA and are enriched in n-6 PUFA in 
comparison with fish tissues (Henderson and Tocher 1987; Tocher et al. 1988).  
       Consequently, we developed a fish cell line, EPC-EFAD, derived from the carp (Cyprinus 
carpio) epithelial papilloma line, EPC, that can survive and proliferate in essential fatty acid-
deficient (EFAD) medium (Tocher et al. 1995).  Proliferation of the EPC-EFAD cells was 
stimulated by supplementing the cells with arachidonic (20:4n-6), eicosapentaenoic (20:5n-3) 
and docosahexaenoic (22:6n-3) acids but not by 18:2n-6 or 18:3n-3 (Tocher et al. 1996). It was 
hypothesized that the differential ability of the PUFA to stimulate proliferation of the EPC-
EFAD cells may be related to the extent of the cells’ ability to desaturate and elongate C18 
PUFA.  In the present study, the metabolism of 14C-labeled C18 and C20 PUFA was investigated 
in EPC-EFAD cells in comparison with EPC cells that were not essential fatty acid deficient.  In 
particular, the effects of essential fatty acid deficiency on fatty acyl desaturation and elongation 
activities were investigated. 
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Materials and methods 
 
Cells and media 
 
The carp (Cyprinus carpio) epithelioma papillosum cell (EPC) line, which retains epithelial 
morphology, was routinely maintained in Leibovitz L-15 medium and supplemented with 2 mM 
glutamine, antibiotics (50 I.U. ml-1 penicillin and 50 mg.ml-1 streptomycin) and 10% fetal bovine 
serum (FBS).  EPC-EFAD cells were derived from EPC cells by subculture in Leibovitz L-15 
medium with exactly the same supplements except that the FBS was delipidated prior to use, 
essentially as described by Capriotti and Laposata (1986).  The delipidated FBS contained 
approximately 10 µg of fatty acids per g of serum (0.001% by weight) with less than 2 µg/g of 
C18 PUFA, predominantly 18:2(n-6) (Tocher et al. 1995,1996).  The EPC-EFAD cells used in the 
experiments had been maintained continuously in delipidated medium for 3 years and were at 
passage number 52-55.  
 
Incubation conditions 
 
The EPC and EPC-EFAD cells were cultured at 22 oC in sealed plastic tissue culture flasks.   
EPC cells were cultured in standard tissue culture flasks (Corning Costar, High Wycombe, 
U.K.), whereas the EPC-EFAD line was cultured in surface-modified “Primaria” flasks (Falcon, 
Becton Dickinson UK Ltd., Oxford).   Both EPC and EPC-EFAD lines were cultured in 75 cm2 
(routine culture for provision of experimental material) or 25 cm2 (14C-metabolism) flasks and 
were subcultured within 24 h of reaching confluence at seeding densities of 1 x 105 cells.cm-2 in 
EPC and 2 x 105 cells.cm-2 in EPC-EFAD, to account for the slower proliferation rate of the 
EPC-EFAD cells in delipidated FBS (Tocher et al. 1995,1996).   For each experimental sample, 
3 x 25 cm2 flasks were seeded and this experiment was repeated three times to obtain the 
                                                  page 6 
replicates. 
 
Incubation of cultures with  14C-labeled polyunsaturated fatty acids 
 
The medium was aspirated, cultures washed with Dulbecco’s phosphate-buffered saline (PBS) 
and fresh Leibovitz L-15 medium, as above but without supplemental serum or delipidated 
serum, was added.  The 14C-labelled PUFAs ([1-14C] 18:2n-6, [1-14C] 18:3n-3, [1-14C] 20:4n-6 
and [1-14C] 20:5n-3; 0.2 µCi per flask; concentration, 0.8 µM) were added to the cell cultures 
bound to fatty acid-free bovine serum albumin (BSA) in phosphate buffered saline (Ghioni et al. 
1997) and incubation continued for 6 days at 22 oC. 
 
Lipid extraction and incorporation of radioactivity into total lipid 
 
The medium was aspirated and cultures washed twice with 20 ml of ice-cold Hanks’ balanced 
salt solution without calcium and magnesium (HBSS).  Cells were harvested by trypsinization 
with 0.05 % trypsin/0.5 mM ethylenediamine tetraacetic acid (EDTA), washed with 5 ml ice-
cold HBSS and a sample taken for protein determination.  The cells were washed with 5 ml 
HBSS containing 1% fatty acid-free BSA and total lipid extracted from the cell pellets with 5 ml 
ice-cold chloroform/methanol (2:1, v/v) containing 0.01% butylated hydroxytoluene (BHT) as 
antioxidant, according to Folch et   al. (1957) as described in detail previously (Tocher et al. 
1988). Lipid content was determined gravimetrically after 1 h vacuum desiccation and the lipid 
resuspended in chloroform/methanol (2:1, v/v) containing BHT, at a lipid concentration of 10 
mg.ml-1, and samples stored at  -20 oC before analyses.   The radioactive content of total lipid 
was determined in 3 aliquots of 5 µl in mini-vials containing 2.5 ml scintillation fluid (Ecoscint 
A; National Diagnostics, Atlanta, USA) using a TRI-CARB 2000CA liquid scintillation 
spectrophotometer (United Technologies Packard).  Results were corrected for counting 
efficiency and quenching using an appropriate calibration curve.   All solvents contained 0.01% 
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BHT as antioxidant. 
 
 
 
Incorporation of radioactivity into glycerophospholipid classes 
 
Samples of total lipid (100 mg) were applied as 1 cm streaks to high-performance thin-layer 
chromatography (HPTLC) plates, and the polar lipid classes separated using methyl 
acetate/propan-2-ol/ chloroform/ methanol/0.25% aqueous KCl (25:25:25:10:9, by vol.) as 
developing solvent (Vitiello and Zanetta, 1978).   After desiccation, the lipid classes were 
visualized by brief exposure to iodine vapor  and areas corresponding to phosphatidylcholine 
(PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), 
phosphatidic acid/cardiolipin  (PA/CL) and total neutral lipid (TN) were scraped into scintillation  
vials containing 2.5 ml scintillation fluid and radioactivity determined as above. 
 
2.6. Incorporation of radioactivity into polyunsaturated fatty acids 
 
Total lipid extracts were transmethylated overnight at 50 oC in methanolic sulfuric acid (Christie 
1982).   Fatty acid methyl esters (FAME) were extracted, after addition of 2 ml 2% KHCO3, with  
hexane/diethyl ether (1:1, v/v) containing 0.01% BHT.  Solvent was evaporated and samples 
were resuspended in 100 µl hexane containing BHT.  Samples were applied as 1 cm streaks on 
HPTLC plates and then developed with hexane/diethyl ether/acetic acid (90:10:1,  by vol.). 
FAME were detected under UV light by comparison with known standards after spraying with 
2’, 7'-dichlorofluorescein. FAME were eluted from the silica with hexane/diethyl ether (1:1, v/v), 
solvent evaporated and the purified samples resuspended in hexane/BHT.   Thin layer 
chromatography (TLC) plates were impregnated  by spraying with 2 g silver nitrate in 20 ml 
acetonitrile and activated at 110 oC for 30 min. FAME were applied as 2.5 cm streaks and plates 
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developed with toluene/acetonitrile (95:5, v/v) to separate PUFA (Wilson  and Sargent 1992).   
Autoradiography was performed using Kodak MR2 film for 7 days at room temperature. Silica 
corresponding to different FAME was scraped into scintillation vials containing 2.5 ml 
scintillation fluid and radioactivity determined as described above. 
 
Lipid class and fatty acid composition 
 
Separation and quantification of lipid classes was performed by single-dimension double-
development HPTLC followed by scanning densitometry as described previously (Henderson 
and Tocher 1992). Fatty acid methyl esters (FAME) were prepared by acid-catalyzed 
transmethylation, extracted and purified by HPTLC as described previously (Tocher and Harvie 
1988). Analysis of FAME was performed by GC in a Fisons GC8000 gas chromatograph 
(Crawley, UK) equipped with a fused-silica capillary column (30m x 0.32 mm i.d., CP Wax 52 
CB, Chrompack, UK) using hydrogen as carrier gas. Temperature programming was from 50 to 
150°C at 35°C/min and to 225°C at 2.5°C/min. Individual FAME were identified by comparison 
with known standards and published data (Ackman 1980; Bell et al. 1983). 
 
Protein determination 
 
The protein content of the cells was determined according to the method of Lowry et al. (1951) 
after incubation with 0.25 ml of 0.25% (wt/vol) sodium dodecyl sulfate/1 M NaOH for 45 min at 
60 oC. 
 
Materials 
 
[1-14C] PUFA (all ~ 50 mCi.mmol-1 and 99% pure) were obtained from NEN Life Science 
Products (Hounslow, U.K.).   Leibovitz L-15 medium, HBSS, PBS, glutamine, penicillin, 
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streptomycin, FBS,  trypsin/EDTA , fatty acid-free BSA and BHT were obtained from Sigma 
Chemical Co. Ltd. (Poole, UK). TLC plates (20 cm x 20 cm x 0.25 mm) and HPTLC plates (10 
cm x 10 cm x 0.15 mm), pre-coated with silica gel 60 were obtained from Merck, (Darmstadt, 
Germany).  All solvents were of HPLC grade and were obtained from Rathburn Chemicals 
(Walkerburn, Peebleshire,  Scotland).     
 
Statistical analysis 
 
All results are means + SD of three experiments. Where indicated, data were subjected to two-
way analysis of variance (ANOVA) and where appropriate the significance of differences were 
determined by Tukey’s test.  Percentage data were subjected to arc-sin transformation prior to 
ANOVA.  When appropriate, the significance of differences between some means were 
determined by the Student t-test.  Differences are reported as significant when p < 0.05 (Zar 
1984). 
 
Results  
 
The lipid content of the essential fatty acid deficient cells (EPC-EFAD) was significantly lower 
than the normal cells (EPC) (Table 1).  Due to this, the absolute amounts of all lipid classes were 
lower in EPC-EFAD cells (data not shown).  In relative terms, both cell lines showed lipid class 
compositions that were predominantly polar lipids with cholesterol as the only major neutral 
lipid with the EPC-EFAD cells having a significantly higher percentage of polar lipids and lower 
cholesterol compared to EPC cells (Table 1).  The proportions of the main phospholipids, 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE), in both cell lines were unchanged 
although the EPC-EFAD cells had significantly increased percentages of many of the more 
minor polar lipids.  Due to the decreased amount of lipid, the absolute amounts of all the fatty 
acid groups were significantly reduced in EPC-EFAD cells (Table 2).  In particular, the lipid of 
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EPC-EFAD cells contained very little (n-3) or (n-6) PUFA, with the totals and all individual 
PUFA being very significantly lower than in EPC cells (Table 2). The relative proportions of 
total saturated fatty acids, in particular the predominant 16:0 and 18:0 acids, were also 
significantly lower in EPC-EFAD cells although shorter chain 12:0 and 14:0 were significantly 
higher.  In contrast, the relative amount of total monounsaturated fatty acids was significantly 
increased in EPC-EFAD cells although the proportion of 18:1n-9 was reduced while the 
proportions of (n-9) PUFA were increased (Table 2). 
     Two-way analysis of variance (ANOVA) showed that the incorporation of 14C-labeled PUFA 
was significantly greater in EPC-EFAD cells irrespective of the PUFA added or the way the 
results were expressed (Table 3).  Irrespective of cell line, i.e. EPC or EPC-EFAD, the 
incorporation [1-14C]20:5n-3 was significantly greater than any other fatty acid and the 
incorporation of [1-14C]20:4n-6 was lower than the other PUFA with the rank order for the 
incorporation being  
20:5n-3 > 18:3n-3 = 18:2n-6 > 20:4n-6. 
      The distribution of radioactivity from the added  14C-labeled PUFA in individual lipid classes 
in EPC and EPC-EFAD cells is shown in Table 4.  Two-way ANOVA showed that this 
distribution was significantly affected by the cell line and was dependent upon the specific 14C-
fatty acid (Table 5). Qualitatively, the distribution of the PUFA was similar in both cell lines, 
with all PUFAs preferentially incorporated into polar lipids.  The incorporation of the 14C-labeled 
C18 PUFAs was greater into PC, phosphatidic acid/cardiolipin (PA/CL) and total neutral lipids, 
compared to the 14C-labeled C20 PUFAs (Tables 4 & 5).  [1-14C]20:5n-3 was preferentially 
incorporated into PE and [1-14C]20:4n-6 was preferentially incorporated into 
phosphatidylinositol (PI).  Quantitatively though, there were significant differences between the 
cell lines.  The proportion of radioactivity from all labeled PUFA recovered in PE and total polar 
lipids was significantly lower in EPC-EFAD cells compared to EPC cells, whereas the 
proportion of radioactivity recovered in all the other phospholipid classes and total neutral lipid 
was increased in EPC-EFAD cells (Tables 4 & 5). 
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      EPC cells metabolized the n-3 PUFA, [1-14C]18:3n-3 and [1-14C]20:5n-3, to a greater extent 
than the corresponding (n-6) substrates (Table 6).  Very little tetraene and pentaene products 
were formed from [1-14C]18:2n-6 and [1-14C]20:4n-6, respectively, in EPC cells.  In contrast, [1-
14C]18:3n-3 was metabolized to 20:5n-3 and 22:6n-3, and [1-14C]20:5n-3 was metabolized to 
22:6n-3 (Table 6).  Desaturation of all the  14C-labeled PUFA was significantly greater in EPC-
EFAD cells compared to EPC cells (Table 6).  With [1-14C]18:2n-6, the proportion of 
radioactivity recovered in the main product of it’s desaturation, 20:3n-6, was significantly 
increased in EPC-EFAD cells, as was 20:4n-6 and 22:4n-6, whereas the proportion of 
radioactivity recovered in 18:2n-6 was significantly reduced.  With [1-14C]18:3n-3, the 
proportions of radioactivity recovered in 20:5n-3, 22:5n-3 and 22:6n-3 were all significantly 
greater and the proportions recovered in almost all the trienes and tetraenes were reduced in 
EPC-EFAD cells (Table 6).  The recovery of radioactivity in 22:6n-3 was significantly greater in 
EPC-EFAD cells incubated with [1-14C]20:5n-3 compared to EPC cells, whereas the proportions 
of radioactivity recovered in 20:5n-3 and it’s elongation products, 22:5n-3 and 22:4n-3, were 
significantly lower.  There was significantly more radioactivity recovered in 22:5n-6 in EPC-
EFAD cells incubated with [1-14C]20:4n-6 compared to EPC cells.  
       The apparent activity at each step in the desaturation/elongation pathway was estimated by 
adding the percentages of radioactivity recovered in all fatty acid metabolites for each step, 
irrespective of subsequent metabolism by another activity (Table 7).  This showed that the 
metabolism of [1-14C]18:2n-6 in EPC-EFAD cells was increased at the level of Δ6 desaturase 
whereas the metabolism [1-14C]18:3n-3 did not appear to be greatly increased at this level.  
However, the desaturation of [1-14C]18:3n-3 appeared to be increased in EPC-EFAD cells at Δ5 
desaturase and subsequent steps although preceding activities may still be influencial. The 
metabolism of [1-14C]20:5n-3 appeared to be primarily increased in EPC-EFAD cells at a step 
after the C20-22 elongase. 
 
Discussion 
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The main effects on lipid composition of three years continuous culture in delipidated serum 
were decreased lipid content and decreased levels of n-3 and n-6 PUFA in EPC-EFAD cells.   
The very low levels of n-3 and n-6 PUFA in EPC-EFAD cells were accompanied by decreased 
proportions of cholesterol, saturates (other than short chain 12:0 and 14:0) and increased 
proportions of n-9 PUFA and monoenes which would compensate for the effects on membrane 
unsaturation and fluidity.   These compositional effects in EPC-EFAD cells were accompanied 
by increased incorporation of the labeled PUFA.   Net “incorporation” is actually based on the 
recovery of radioactivity and represents uptake minus the amount oxidized or lost via other 
metabolic pathways.  However, all fatty acids were used at the same concentration and so the 
amount taken up and oxidized will only be dependent on the fatty acid and the cell type. The 
differences in incorporation between the fatty acids were similar in the two cell lines showing 
that essential fatty acid deficiency had affected these processes similarly for all fatty acids. 
      However, the primary aims of the present study were to precisely determine the ability of 
EPC cells to desaturate and elongate PUFA, particularly C18 PUFA,  and to investigate the effects 
of essential fatty acid deficiency on that pathway.   The results of the present study demonstrated 
that the EPC cell line is capable of desaturating 18:3n-3 to 20:5n-3 and, to a lesser extent, 22:6n-
3.  Similarly, 18:2n-6 was converted to 20:4n-6 in EPC cells although 20:3n-6 was the main 
product.  EPC-EFAD cells also exhibited the full desaturation/elongation pathway and indeed 
essential fatty acid deficiency significantly increased the desaturation of 18:3n-3 to 20:5n-3 and 
22:6n-3, and 18:2n-6 to 20:4n-6. 
      The aims of the present study arose from previous studies that had shown that C18 PUFA 
(18:3n-3 and 18:2n-6) did not stimulate proliferation of EPC-EFAD cells, whereas C20 and C22 
PUFA (20:4n-6, 20:5n-3 and 22:6n-3) were effective in increasing the proliferation rate of the 
essential fatty acid deficient cells (Tocher et al. 1996). The fatty acid compositional data in the 
previous study had suggested that the EPC-EFAD cells had only limited Δ5 desaturase activity 
based on the fact that the level of 20:4n-6 in total lipid was not significantly increased after 
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supplementation with 18:2n-6 and that the levels of 20:5n-3 (and 22:6n-3) were not increased 
after supplementing with 18:3n-3 (Tocher et al. 1996).  This was unexpected as, firstly, the EFA 
requirements of common carp are known to be met by C18 PUFA alone, specifically about 1% 
each of 18:3n-3 and 18:2n-6 (Takeuchi and Watanabe 1977).  Secondly, a deficiency in the 
desaturase pathway had been widely perceived to be a trait of marine fish, especially carnivorous 
marine fish, and so it was unexpected to have an apparent deficiency in a cell line from a largely 
herbivorous freshwater species (Sargent et al. 1995; Tocher et al. 1998). However, it was known 
that many cultured cell lines appear to lack, or display low levels of activity, of certain enzymes 
of the fatty acid desaturation/elongation pathway (Tocher et al. 1998). Therefore, it was possible 
that EPC (and EPC-EFAD) cells no longer reflected the situation in carp and had lost an enzyme 
activity in the fatty acid desaturation/elongation pathway.  The present study has demonstrated 
that this is not the case and that both the EPC and EPC-EFAD cell lines have the fatty acid 
desaturation/elongation profile expected of cells from a freshwater fish. 
       In the previous study, levels of 20:4n-6 and 20:5n-3 were increased by supplementing EPC-
EFAD cells with 20:4n-6 and 20:5n-3, and 20:5n-3 was also very significantly increased by 
supplementation with 22:6n-3 (Tocher et al. 1996).  In contrast, 20:5n-3 and 20:4n-6 were not 
increased by supplementing EPC-EFAD cells with 50 µM unlabeled 18:3n-3 and 18:2n-6, 
respectively.  This had suggested that eicosanoids may be implicated in the mechanism of 
stimulation of proliferation (Tocher et al. 1996).  The data from the present study is not 
inconsistent with the data from the previous study and can support the view that eicosanoids are 
involved.  In the previous study, 20:3n-6 was significantly increased by supplementing with 
18:2n-6 and this is supported by the data in the present study which shows that 20:3n-6 was the 
main product of [1-14C]18:2n-6 desaturation and that the residual 18:2n-6 (~1.5 µg/g) in 
delipidated serum is converted to 20:3n-6.   A relative accumulation of radioactivity in EFA 
deficient human Hep G2 cells incubated with tracer amounts of 14C-labelled 18:2n-6 was 
reported previously (Melin and Nilsson 1997).  Similarly, supplementing EPC-EFAD cells with 
18:3n-3 in the previous study significantly increased the levels of both 20:3n-3 and 20:4n-3, and 
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20:4n-3 was a major product of [1-14C]18:3n-3 desaturation in the present study.  It is well 
known that 20:3n-6 can modulate the production and efficacy of 20:4n-6-derived eicosanoids via 
competitive inhibition and as the precursor of eicosanoids with attenuated biological properties 
(Horrobin 1992; Bell et al. 1994).  Similarly, 20:4n-3 can be converted to eicosanoids with 
attenuated properties in mammalian tissues and inhibit 20:4n-6 metabolism in human leukocytes 
(Oliw et al. 1986a,b; Samel et al. 1987; Careaga and Sprecher 1987; Guichardant et al. 1993).  
Eicosanoids, particularly prostaglandins, are known to be highly involved in the regulation of 
cellular proliferation (Wickremasinghe 1988; Skouteris et al. 1988 ) including fish cells 
(Secombes et al. 1994; Rowley et al. 1995). 
        Therefore, the data in the present study are consistent with 18:2n-6 failing to stimulate 
proliferation of EPC-EFAD cells due to the accumulation of 20:3n-6 rather than 20:4n-6.  
However, although the present data can explain the accumulation of both 20:3n-3 and 20:4n-3 in 
EPC-EFAD cells supplemented with 18:3n-3 it is unclear why 18:3n-3 did not appear to be 
significantly converted to 20:5n-3 and 22:6n-3 in the earlier study.   This discrepancy between 
the two studies may be related to fatty acid concentration as a relatively high concentration of 50 
µM was used previously whereas the labeled fatty acids in the present study were used at tracer 
concentrations of less than 1 µM.  Differences in metabolism due to fatty acid concentration have 
been noted previously (Melin and Nilsson 1997). 
           Essential fatty acid deficiency had other effects on PUFA metabolism in EPC cells.  In 
EPC-EFAD cells, the distribution of the PUFA in phospholipid classes was altered with the main 
effect, observed with all the PUFA, being decreased amounts incorporated in PE and increased in 
PC.  This may reflect lowered specificity between phospholipid classes in EPC-EFAD cells, in 
which all the phospholipids are essentially lacking their normal complement of PUFA.  
Therefore, PC, the predominant phospholipid class, accumulates relatively more PUFA in EPC-
EFAD cells than in EPC cells. However, alterations in the relative incorporation of PUFA into 
PC and PE have been observed before in fish cell lines in response to other factors such as 
culture temperature (Tocher and Sargent 1990) and xenobiotics (Ghioni et al. 1998).  Alterations 
                                                  page 15 
in the relative proportions of PC and PE are also common in adaptation of fish to environmental 
factors such as temperature, salinity and hydrostatic pressure (Tocher 1995) but no such 
alteration was observed in response to EFA deficiency in the present study.    
      In comparison with salmonid cell lines, EPC cells were similar to Atlantic salmon (AS) cells 
in which 20:4n-3 was the predominant product of 18:3n-3 desaturation rather than 20:5n-3, as in 
rainbow trout (RTG-2) cells (Tocher and Sargent 1990; Ghioni et al. 1998).  However, EPC cells 
and, especially, EPC-EFAD cells produced far more 22:6n-3, both from [1-14C]18:3n-3 and [1-
14C]20:5n-3, than the other freshwater cell lines investigated previously (Tocher and Sargent 
1990; Ghioni et al. 1998).   It was noteworthy that the effect of essential fatty acid deficiency on 
the desaturation and elongation of [1-14C]18:3n-3 and [1-14C]18:2n-6 was different.   The 
production of Δ5 products of [1-14C]18:3n-3 was doubled in EPC-EFAD cells and the 
radioactivity recovered in 22:6n-3 was over 4-fold higher whereas there was apparently less 
effect on Δ6 desaturase and C18-20 elongase.  With [1-14C]18:2n-6, Δ5 products were also 
increased by about 10-fold in EPC-EFAD cells but Δ6 desaturase products were also doubled.   
The precise reason for the apparent difference in the pathway using the different C18 PUFA 
substrates is not known but it is important to appreciate that the data for C18-20 elongase and all 
subsequent enzymes are, of course, not independent of preceding activities and labeled versions 
of the direct substrates of each activity are required to further investigate this apparent effect.  
Previously, it was shown that both Δ6 and Δ5 desaturases in human Hep G2 cells incubated with 
14C-labeled 18:2n-6 were apparently both rate-limiting and upregulated in EFA deficiency (Melin 
and Nilsson 1997). 
       In conclusion, the present study has demonstrated that the carp cell line, EPC, has a 
complete fatty acid desaturation and elongation pathway, and can biosynthesize 22:6n-3 from 
18:3n-3 and 20:4n-6 from 18:2n-6.  The overall desaturation of PUFA was increased by essential 
fatty acid deficiency with apparently increased desaturase activities, rather than increased 
elongase activities, in EPC-EFAD cells.  Therefore, the previously reported inability of 18:3n-3 
and 18:2n-6, in comparison to C20 and C22 PUFA, to stimulate proliferation of EPC-EFAD cells 
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was not due to a general deficiency in the desaturase pathway.  However, it may be related to 
accumulation of 20:4n-3 and 20:3n-6, with their associated potential to alter eicosanoid profiles, 
in cells supplemented with C18 PUFA although this requires further investigation.  
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Table 1.  Effect of essential fatty acid deficiency on lipid content and lipid class  
composition (percentage of total lipid) of EPC cells grown at 22 oC in  
10% FBS (EPC) or for three years in delipidated FBS (EPC-EFAD). 
 
___________________________________________________________ 
 
Lipid                                                           EPC                   EPC-EFAD          
___________________________________________________________ 
 
Total lipid content 
 µg lipid /106 cells                                  17.9 ± 1.3               11.0 ± 0.8*   
 
Lipid class composition 
 
Phosphatidylcholine                               27.2 ± 1.1              26.4 ± 0.1                              
 
Phosphatidylethanolamine                      23.6 ± 0.1              24.6 ± 0.4                              
 
Phosphatidylserine                                    6.8 ± 0.1               8.7 ± 0.2*                                
 
Phosphatidylinositol                                  6.1 ± 0.0               5.0 ± 0.1*                               
 
Phosphatidic acid/cardiolipin                     3.1 ± 0.3               3.2 ± 0.2                              
 
Sphingomyelin                                           7.9 ± 0.3              9.5 ± 0.3*                               
 
Sulfatides/cerebrosides                              1.4 ± 0.2               2.8 ± 0.1*                                                                                     
 
  
Total polar lipids                                      76.1 ± 1.7             80.2 ± 0.8*                          
 
Total neutral lipids                                    23.9 ± 1.7            19.8 ± 0.8*                              
 
 
Cholesterol                                               22.1 ± 1.0            19.0 ± 0.6*                                
 
Triacylglycerol                                           1.2 ± 0.1              0.8 ± 0.2                               
 
Steryl ester                                                 0.6 ± 0.5                   n.d.                                
 
Free fatty acids                                                 tr                         n.d.                                    
___________________________________________________________ 
 
Results are means ± S.D. (n=3); n.d., not detected; tr, trace (< 0.05%).  
* EPC-EFAD cells significantly different to EPC cells (p < 0.05) as  
determined by the Student’s t-test. 
 
 
                                                  page 23 
Table 2.  Effect of essential fatty acid deficiency on fatty acid compositions of total lipid from EPC cells grown 
at 22oC in 10% FBS (EPC) or for three years in delipidated FBS (EPC-EFAD). 
__________________________________________________________________________________________ 
                                                       Percentage of weight                                              µg/million cells 
                                          _______________________________                ______________________________ 
Fatty acid                                 EPC                       EPC-EFAD                            EPC                         EPC-EFAD                                                     
________________________________________________________________________________________ 
14:0                                       0.7 ± 0.1                    2.9 ± 0.1*                        0.08 ± 0.01                0.21 ± 0.01*                                           
15:0                                       0.1 ± 0.0                    0.4 ± 0.0*                        0.01 ± 0.00                0.03 ± 0.00*                                                  
16:0                                     13.1 ± 0.1                    9.4 ± 0.1*                        1.47 ± 0.01                0.68 ± 0.01*                                      
17:0                                       0.3 ± 0.1                         n.d.                             0.03 ± 0.01                        n.d.                            
18:0                                       7.1 ± 0.1                    2.1 ± 0.1*                        0.80 ± 0.01                0.15 ± 0.01* 
20:0                                       0.2 ± 0.0                    0.2 ± 0.0                          0.02 ± 0.01                0.01 ± 0.00 
22:0                                            n.d.                       1.0 ± 0.1*                              n.d.                       0.07 ± 0.01* 
24:0                                            n.d.                       0.5 ± 0.0*                              n.d.                       0.04 ± 0.00*                                                                                                                    
Total saturated                      21.5 ± 0.5                 16.5 ± 0.1*                        2.41 ± 0.06                1.19 ± 0.01*                                                   
16:1(n-9)                                2.7 ± 0.1                   1.8 ± 0.0*                        0.30 ± 0.01                0.12 ± 0.00*                                                   
16:1(n-7)                                2.2 ± 0.1                   5.7 ± 0.1*                        0.25 ± 0.01                0.41 ± 0.01*                                
18:1(n-9)                              34.9 ± 0.1                 31.9 ± 0.1*                        3.91 ± 0.01                2.30 ± 0.01*                           
18:1(n-7)                                4.7 ± 0.2                 10.8 ± 0.1*                        0.53 ± 0.02                0.78 ± 0.01* 
18:1(n-5)                                      n.d.                     2.3 ± 0.1*                               n.d.                      0.14 ± 0.01*                             
20:1(n-11)                                    n.d.                     0.8 ± 0.0*                               n.d.                      0.06 ± 0.00*   
20:1(n-9)                                3.5 ± 0.1                   2.8 ± 0.0*                        0.34 ± 0.01                 0.20 ± 0.00*                                           
20:1(n-7)                                0.3 ± 0.1                   0.9 ± 0.1*                        0.03 ± 0.01                 0.06 ± 0.01                                                                                                           
22:1                                        0.5 ± 0.0                   3.2 ± 0.1*                        0.06 ± 0.00                 0.23 ± 0.01* 
24:1                                        1.2 ± 0.1                   2.0 ± 0.0*                        0.13 ± 0.01                 0.14 ± 0.00                                                
Total monounsaturated         50.1 ± 0.3                 62.2 ± 0.0*                        5.61 ± 0.03                 4.48 ± 0.00* 
18:2(n-9)                                0.8 ± 0.1                   0.7 ± 0.0                          0.09 ± 0.01                 0.05 ± 0.00*                                       
20:2(n-9)                                4.2 ± 0.0                   5.4 ± 0.1*                        0.47 ± 0.00                 0.39 ± 0.01*                                      
20:3(n-9)                                2.7 ± 0.1                   3.4 ± 0.0*                        0.30 ± 0.01                 0.25 ± 0.00* 
C22(n-9)                                0.2 ± 0.0                   1.0 ± 0.0*                        0.02 ± 0.00                 0.07 ± 0.00*                                                                                             
Total (n-9) PUFA                   7.9 ± 0.1                 10.5 ± 0.1*                       0.88 ± 0.01                 0.76 ± 0.01*                       
18:2(n-6)                                0.9 ± 0.1                   0.7 ± 0.1                          0.10 ± 0.01                0.05 ± 0.01*                             
18:3(n-6)                                      n.d.                           n.d.                                    n.d.                           n.d. 
20:2(n-6)                                0.3 ± 0.1                         n.d.                             0.03 ± 0.01                      n.d.                                   
20:3(n-6)                                1.4 ± 0.0                   0.5 ± 0.1*                         0.16 ± 0.00               0.04 ± 0.0*                                               
20:4(n-6)                                3.8 ± 0.0                         n.d.*                           0.43 ± 0.00                      n.d.*                                                                                      
C22(n-6)                                 0.4 ± 0.1                        n.d.*                           0.05 ± 0.01                      n.d.* 
Total (n-6) PUFA                    6.8 ± 0.2                 1.2 ± 0.2*                         0.67 ± 0.02                0.09 ± 0.01*                                                                                              
18:3(n-3)                                       n.d.                          n.d.                                   n.d.                             n.d. 
18:4(n-3)                                       n.d.                          n.d.                                   n.d.                             n.d.                                                                  
20:4(n-3)                                       n.d.                          n.d.                                   n.d.                             n.d.                                                                              
20:5(n-3)                                  0.3 ± 0.0                       n.d.*                           0.03 ± 0.00                      n.d.*                                  
22:5(n-3)                                  1.5 ± 0.0                       n.d.*                           0.17 ± 0.00                      n.d.*                               
22:6(n-3)                                  2.6 ± 0.1                 0.2 ± 0.0*                         0.29 ± 0.01               0.01 ± 0.00*                                         
Total (n-3) PUFA                     4.4 ± 0.1                 0.2 ± 0.0*                         0.49 ± 0.01               0.01 ± 0.00*                                   
Total dimethylacetals                4.9 ± 0.1                  5.8 ± 0.4*                        0.55 ± 0.01               0.42 ± 0.03*                                 
Total PUFA                            19.1 ± 0.2                11.9 ± 0.3*                        2.04 ± 0.02               0.86 ± 0.02*                         
Total unidentified                     4.4 ± 0.6                  3.6 ± 0.4                           0.49 ± 0.07               0.26 ± 0.03*                           
_______________________________________________________________________________________ 
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Results are means ± S.D. (n=3); n.d., not detected; PUFA,  polyunsaturated fatty acids. * EPC-EFAD cells 
significantly different to EPC cells (p < 0.05) as determined by the Student’s t-test. 
 
 
 
 
Table 3.  Effect of essential fatty acid deficiency on the incorporation of [1-14C] polyunsaturated fatty acids 
(PUFA) into EPC cells. 
 
__________________________________________________________________________________________ 
 
                                                                       Incorporation                                        Incorporation 
                                                                  (pmol / mg total lipid)                           (pmol / million cells) 
                                                   _______________________________  ________________________________ 
                                                                                 
[1-14C]PUFA                                    EPC            EPC-EFAD     Sign.             EPC             EPC-EFAD     Sign.          
________________________________________________________________________________________         
 
[1-14C]18:3n-3                            4.54 ± 0.40      7.81 ± 0.83        b           0.54 ± 0.05       0.64 ± 0.04        b 
 
[1-14C]18:2n-6                            4.61 ± 0.59      6.19 ± 1.59       bc          0.47 ± 0.05       0.71 ± 0.13        b 
 
[1-14C]20:4n-6                            3.28 ± 0.14      4.92 ± 0.78        c           0.32 ± 0.05       0.48 ± 0.04        c      
 
[1-14C]20:5n-3                             6.77 ± 0.18    12.90 ± 0.69       a           0.72 ± 0.18       1.05 ± 0.02        a 
__________________________________________________________________________________________ 
 
Results are means ± SD ( n = 3).  For each way of expressing the data (pmol incorporated per mg total lipid or 
million cells), the significance of differences between cell types (EPC and EPC-EFAD) and treatments 
(labelled fatty acids) were analysed by two-way analysis of variance (ANOVA) and, where appropriate, 
Tukey’s multiple comparison test.  Incorporation of radioactive PUFA was significantly greater in EPC-EFAD 
cells (p < 0.05) irrespective of the way the incorporation was expressed.  Differences between fatty acids for 
each way of expressing incorporation are indicated by letters, e.g. incorporation of [1-14C]20:5n-3 was 
significantly greater than the incorporation of any other fatty acid whichever way that incorporation was 
expressed. 
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Table 4.  Effect of essential fatty acid deficiency on the incorporation of [1-14C] polyunsaturated fatty acids  
(PUFA) into phospholipid classes in EPC cells. 
 
______________________________________________________________________________ 
 
                                                    [1-14C]18:2n-6                                       [1-14C]20:4n-6 
                                   _____________________________     _____________________________ 
 
Lipid class                           EPC                  EPC-EFAD                     EPC                 EPC-EFAD 
______________________________________________________________________________ 
 
PC                                  35.7 ± 0.6             38.5 ± 0.2                 11.0 ± 0.5             13.9 ± 0.2            
PE                                  34.7 ± 0.6             24.3 ± 0.3                 48.6 ± 2.2             34.2 ± 0.3       
PS                                  10.1 ± 0.3               8.3 ± 0.2                   3.3 ± 0.1               3.8 ± 0.1       
PI                                     3.7 ± 0.1               8.5 ± 0.2                 29.7 ± 2.2             40.6 ± 1.2       
PA/CL                            12.6 ± 0.5             15.9 ± 0.2                   5.3 ± 0.6               6.1 ± 0.6       
 
TP                                  96.8 ± 0.2             95.5 ± 0.2                 97.9 ± 0.1             98.6 ± 0.2       
TN                                   3.2 ± 0.2               4.5 ± 0.2                   2.1 ± 0.1               1.4 ± 0.2       
______________________________________________________________________________ 
 
                                                   [1-14C]18:3n-3                                        [1-14C]20:5n-3 
                                   _____________________________     _____________________________ 
 
Lipid class                           EPC                  EPC-EFAD                    EPC                  EPC-EFAD 
______________________________________________________________________________ 
 
PC                                  33.2 ± 1.0             34.1 ± 0.4                 19.7 ± 0.1             28.1 ± 1.4       
PE                                  45.1 ± 0.9             39.1 ± 0.6                 62.9 ± 0.4             50.7 ± 0.9       
PS                                    7.5 ± 0.2               9.8 ± 0.2                   9.2 ± 0.4             10.9 ± 0.2       
PI                                     2.5 ± 0.0               3.0 ± 0.2                   3.7 ± 0.4               4.3 ± 0.2       
PA/CL                              9.1 ± 0.2             11.6 ± 0.2                   3.2 ± 0.5               4.3 ± 0.1       
 
TP                                  97.4 ± 0.1             97.6 ± 0.2                 98.7 ± 0.1             98.3 ± 0.2       
TN                                   2.6 ± 0.1               2.4 ± 0.2                   1.3 ± 0.1               1.7 ± 0.2       
______________________________________________________________________________ 
 
Results are expressed as percentages of total radioactivity recovered and are means ± SD (n = 3). 
CL, cardiolipin; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine;  
PI, phosphatidylinositol; PS, phosphatidylserine; TN, total neutral lipids; TP, total polar lipids. 
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Table 5.  Results of two-way analysis of variance (ANOVA) for the data in Table 4. 
 
____________________________________________________________________________________ 
 
                        Effect of       Effects of     Interaction                                 Multiple range tests                        
Lipid class        cell line       fatty acids                                  cell line                           fatty acids 
____________________________________________________________________________________ 
 
PC                         *                   *                   *           EPC < EPC-EFAD       18:2 > 18:3 > 20:5 > 20:4   
 
PE                         *                   *                   *           EPC > EPC-EFAD       20:5 > 18:3 = 20:4 > 18:2   
 
PS                         *                   *                   *           EPC < EPC-EFAD       20:5 > 18:2 > 18:3 > 20:4   
 
PI                          *                   *                   *           EPC < EPC-EFAD       20:4 > 18:2 > 20:5 = 18:3   
 
PA/CL                   *                   *                   *           EPC < EPC-EFAD       18:2 > 18:3 > 20:4 > 20:5   
 
TP                         *                   *                   *           EPC > EPC-EFAD       20:5 > 20:4 > 18:3 > 18:2   
 
TN                        *                   *                   *            EPC < EPC-EFAD      18:2 > 18:3 > 20:4 > 20:5   
____________________________________________________________________________________ 
 
CL, cardiolipin; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine;  
PI, phosphatidylinositol; PS, phosphatidylserine; TN, total neutral lipids; TP, total polar lipids.  
 *, significant at p < 0.05. 
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Table 6.  Effect of essential fatty acid deficiency  on the metabolism of [1-14C] polyunsaturated fatty  
acids (PUFA) by desaturation and elongation in EPC cells. 
______________________________________________________________________________ 
 
                                                    [1-14C]18:2n-6                                       [1-14C]20:4n-6 
                                   _____________________________     _____________________________ 
 
Fatty acid                             EPC                EPC-EFAD                      EPC                 EPC-EFAD 
______________________________________________________________________________ 
 
18:2n-6                          74.4 ± 0.8             55.0 ± 0.5*                      n.d.                       n.d.            
20:2n-6                            8.5 ± 0.6             10.5 ± 0.2*                      n.d.                       n.d.      
18:3n-6                            2.3 ± 0.1               3.9 ± 0.2*                      n.d.                       n.d.       
20:3n-6                          14.3 ± 0.2             24.8 ± 0.5*                      n.d.                       n.d.     
22:3n-6                                   t                      0.5 ± 0.1*                      n.d.                       n.d.       
20:4n-6                            0.5 ± 0.1               2.6 ± 0.1*               96.3 ± 0.9             94.9 ± 0.8       
22:4n-6                                 n.d.                  2.5 ± 0.2*                 1.5 ± 0.4               1.9 ± 0.3     
24:4n-6                                 n.d.                       n.d.                      1.9 ± 0.5               2.0 ± 0.2      
22:5n-6                                 n.d.                  0.2 ± 0.1                   0.3 ± 0.1               1.2 ± 0.4*     
______________________________________________________________________________ 
 
                                                   [1-14C]18:3n-3                                        [1-14C]20:5n-3 
                                   _____________________________     _____________________________ 
 
Fatty acid                             EPC                EPC-EFAD                      EPC                 EPC-EFAD 
______________________________________________________________________________ 
 
18:3n-3                          21.1 ± 0.3             17.6 ± 0.5*                      n.d.                       n.d.            
20:3n-3                          17.6 ± 0.8             13.5 ± 0.6*                      n.d.                       n.d.      
18:4n-3                             7.0 ± 0.1               8.2 ± 0.4*                     n.d.                       n.d.       
20:4n-3                           28.4 ± 1.0             18.2 ± 0.7*                     n.d.                       n.d.     
22:4n-3                             4.1 ± 0.5               1.9 ± 0.2*                     n.d.                       n.d.       
20:5n-3                             8.1 ± 0.3             13.7 ± 0.4*               29.8 ± 3.5             39.3 ± 1.3*       
22:5n-3                           11.0 ± 0.6             15.0 ± 0.1*               40.7 ± 0.1             32.0 ± 1.2*     
24:5n-3                                 n.d.                       n.d.                     17.8 ± 0.4               6.7 ± 0.2*      
22:6n-3                            2.7 ± 0.2             11.9 ± 0.2*               11.7 ± 4.0             22.1 ± 0.9*   
______________________________________________________________________________ 
Results are expressed as percentages of total radioactivity recovered in total lipid and are means ± SD  
(n = 3). Differences between values for EPC and EPC-EFAD cells for each [1-14C] PUFA were  
significantly different where indicated (*) as determined by the Student t-test (p < 0.05). 
n.d., not detected.  
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